-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TfKCXwt08FNYECNHmTXtgpUn4En8vZXMFm6mZlAU9+a6WYbszjBoQUuDYH7cypFr oGKLQVIUXEGz6TP3LRDz/Q== /in/edgar/work/20000530/0000097745-00-000045/0000097745-00-000045.txt : 20000919 0000097745-00-000045.hdr.sgml : 20000919 ACCESSION NUMBER: 0000097745-00-000045 CONFORMED SUBMISSION TYPE: 425 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20000530 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: THERMEDICS INC CENTRAL INDEX KEY: 0000721356 STANDARD INDUSTRIAL CLASSIFICATION: [3590 ] IRS NUMBER: 042788806 STATE OF INCORPORATION: MA FISCAL YEAR END: 0102 FILING VALUES: FORM TYPE: 425 SEC ACT: SEC FILE NUMBER: 001-09567 FILM NUMBER: 645804 BUSINESS ADDRESS: STREET 1: 470 WILDWOOD ST STREET 2: P O BOX 2697 CITY: WOBURN STATE: MA ZIP: 01888-1799 BUSINESS PHONE: 7816221000 MAIL ADDRESS: STREET 1: 81 WYMAN STREET STREET 2: P.O. BOX 9046 CITY: WALTHAM STATE: MA ZIP: 02254 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: THERMO ELECTRON CORP CENTRAL INDEX KEY: 0000097745 STANDARD INDUSTRIAL CLASSIFICATION: [3829 ] IRS NUMBER: 042209186 STATE OF INCORPORATION: DE FISCAL YEAR END: 0102 FILING VALUES: FORM TYPE: 425 BUSINESS ADDRESS: STREET 1: 81 WYMAN ST STREET 2: P O BOX 9046 CITY: WALTHAM STATE: MA ZIP: 02454 BUSINESS PHONE: 7816221000 425 1 0001.txt FORM 425 Filer: Thermo Electron Corporation Subject Company: Thermedics Inc. Subject Company Exchange Act File No.: 1-9567 Registration Statement No.: 333-35982 PRESS RELEASE Investor Contact: 781-622-1111 Media Contact: 781-622-1252 Thermo Electron Extends Exchange Offer for Thermedics Shares to June 9, 2000 WALTHAM, Mass., May 30, 2000 - Thermo Electron Corporation (NYSE-TMO) announced that it has extended the offer for Thermedics Inc. (ASE-TMD) common stock until midnight on June 9, 2000. This extension is required because the Securities and Exchange Commission (SEC) has not yet completed its review of Thermo Electron's registration statement for the exchange offer. The company may not accept shares of Thermedics common stock tendered in the exchange offer until the registration statement is declared effective by the SEC. Other terms and conditions of the exchange offer remain unchanged. According to a preliminary report from the depositary for the exchange offer, approximately 7.7 million shares of Thermedics common stock had been tendered and not withdrawn pursuant to the exchange offer as of the close of business on Friday, May 26, 2000. These shares represent approximately 18 percent of total Thermedics shares outstanding, and when combined with shares held by Thermo Electron, represent approximately 94 percent. Because of the extension announced today, holders of Thermedics common stock may tender or withdraw their shares until midnight on Friday, June 9, 2000, unless the exchange offer is further extended. The exchange offer previously had been scheduled to expire at midnight on May 26, 2000. On May 1, 2000, Thermo Electron mailed a preliminary prospectus to registered holders of Thermedics shares regarding the exchange offer and the merger, accompanied by a letter of transmittal that Thermedics shareholders can use to tender their shares in the exchange offer. Beneficial owners of Thermedics shares holding in street name through their brokers can receive the preliminary prospectus and letter of transmittal from their broker and should contact their brokers for those documents. In any case, copies of the preliminary prospectus and letter of transmittal may be requested from D.F. King & Co., Inc., the information agent for the exchange offer, by calling (800) 290-6433. Thermo Electron Corporation is a leading provider of analytical and monitoring instruments used in a broad range of applications, from life sciences research to telecommunications to food and beverage production. In addition, Thermo Electron serves the healthcare market through a family of medical products, and is a major producer of paper recycling systems and provides water-clarification and fiber-recovery products and services. As announced on January 31, 2000, the company has initiated a major reorganization that would transform it into one company focused on its core measurement and detection instruments business. More information is available on the Internet at http://www.thermo.com. -more- Other Important Information: We urge investors and security holders to read the following documents when they become available, regarding the exchange offer and the merger described in this announcement, because they contain important information: Thermo Electron's preliminary prospectus, any prospectus supplement, final prospectus, and other exchange offer materials. Thermo Electron's registration statement on form S-4 and Schedule TO, as amended, which contain or incorporate by reference the documents listed above and other information. Thermedics' solicitation/recommendation statement on schedule 14D-9. These documents and amendments to these documents have been or will be filed with the SEC. When these and other documents are filed with the SEC, they may be obtained for free at the SEC's Web site at www.sec.gov. You may also obtain for free each of these documents, when available, from us. You can call us at (781) 622-1111 or write to us at: Investor Relations Department Thermo Electron Corporation 81 Wyman Street, P.O. Box 9046 Waltham, MA 02454-9046 The following constitutes a "Safe Harbor" statement under the Private Securities Litigation Reform Act of 1995: This press release contains forward-looking statements that involve a number of risks and uncertainties. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are set forth under the heading "Forward-Looking Statements" in Exhibit 13 to the company's annual report on Form 10-K, for the year ended January 1, 2000. These include risks and uncertainties relating to: the company's corporate reorganization, acquisition strategy, growth strategy, international operations, product development and technological change, possible changes in governmental regulations, changes in both capital spending by commercial customers and government funding policies, and dependence on intellectual property rights. # # # -----END PRIVACY-ENHANCED MESSAGE-----